29 November 2022
: Case report 
Diagnostic Pitfalls of Chylothorax After Dasatinib Treatment of Chronic Myeloid Leukemia
Unknown etiology, Mistake in diagnosis, Adverse events of drug therapy
Ryan L. Kelly1EF*, Ju Young Bae
1E, Samantha D'Annunzio2E, Francesca Montanari3DE
DOI: 10.12659/AJCR.938319
Am J Case Rep 2022; 23:e938319
Table 1. Admission laboratory findings and pleural fluid analysis.
| Admission Labs | ||
|---|---|---|
| Sodium | 137 | 136–145 mmol/L |
| Potassium | 3.5–5.1 mmol/L | |
| Chloride | 107 | 99–109 mmol/L |
| CO2 | 22 | 21–32 mmol/L |
| Anion gap | 8 | 5.0–18.0 |
| BUN | 12 | 8–25 mg/dL |
| Creatinine | 0.68 | 0.5–1.3 mg/dL |
| Glucose | 86 | 70–100 mg/dL |
| Calcium | 9.3 | 8.4–10.3 mg/dL |
| Total bilirubin | 0.2 | 0.0–1.0 mg/dL |
| Alkaline phosphatase | 101 | 20–120 U/L |
| ALT | 23 | 12–78 U/L |
| AST | 21 | 5–37 U/L |
| Cholesterol | 50–200 mg/dL | |
| HDL | 46 | 40–90 mg/dL |
| Triglycerides | 30–200 mg/dL | |
| LDL (calculated) | 20–130 mg/dL | |
| LD | 174 | 35–190 U/L |
| ProBNP | 108 | 0–450 pg/mL |
| Troponin | <0.015 | 0–1.5 ng/mL |
| CRP | 0–1 mg/dL | |
| ESR | 0–20 mm/hr | |
| Procalcitonin | <0.04 | <0.26 ng/mL |
| D-dimer | <0.49 mg/L | |
| TSH | 0.358–3.74×ulU/mL | |
| Free T4 | 1.33 | 0.76–1.46 ng/dL |
| WBC | 5 | 3.8–10.6×1000/uL |
| RBC | 3.3 | 4.2–5.4 M/uL |
| Hemoglobin | 11.9–16.0 g/dL | |
| Hematocrit | 33.6 | 36.0–48.0% |
| Platelets | 301 | 140–446×1000/uL |
| Pleural protein | 5.3 | g/dL |
| Glucose | 123 | mg/dL |
| LDH | 136 | U/L |
| Amylase | 56 | U/L |
| Lipase | 95 | U/L |
| Cholesterol | 61 | mg/dL |
| Triglyceride | 481 | mg/dL |
| pH | 7.44 | |
| Serum LDH | 174 | 35–190 U/L |
| Serum total protein | 7.4 | 6.4–8.2 g/dL |